Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Novo Nordisk, the maker of Ozempic and Wegovy weight-loss drugs, just regained the title as Europe’s most valuable company ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Influencers on TikTok have been banned after they were found to be promoting drugs like Ozempic and Mounjaro through their social media ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

WEIGHT loss jabs could one day be dished out like statins, England’s top doctor says. Professor Sir Stephen Powis, medical ...

Louisiana is facing a significant obesity challenge, ranking fourth in the nation for obesity rates. As a result, many residents are turning to weight loss drugs like Ozempic and Wegovy.

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...

Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.